スポンサーリンク
Anaeropharma Science Inc. | 論文
- GERMLINE MUTATIONS OF THE APC GENE IN TWO JAPANESE ADENOMATOUS POLYPOSIS PATIENTS
- Genetically engineered Bifidobacterium longum for tumor-targeting enzyme-prodrug therapy of autochthonous mammary tumors in rats
- Cardiac Myxoma : Its Origin and Tumor Characteristics
- Cloned Cytosine Deaminase Gene Expression of Bifidobacterium longum and Application to Enzyme/Pro-drug Therapy of Hypoxic Solid Tumors(Biochemistry & Molecular Biology)
- Stromal sarcoma of the breast with leiomyosarcomatous pattern
- The Likely Transformation of Papillary Thyroid Carcinoma into Anaplastic Carcinoma During Postoperative Radioactive Iodine-131 Therapy : Report of a Case
- Tumor Marker Levels Elevate False-Positively in Postsurgical Breast Cancer Patients with High sGPT Levels or with Receiving Oral 5-FU or Its Derivatives
- Allelic Loss of the Region of Chromosome 1p35-pter Is Associated with Progression of Human Gastric Carcinoma
- Briateral Synchronous Spindle Cell, Apocrine and Scirrhous Carcinoma Breast Cancer in a Case of Malignant Lymphoma
- A Case of Occult Breast Cancer with Paraneoplastic Polyneuropathy
- Postoperative Outcome of Insufficient Surgery for Small Differentiated Thyroid Carcinoma
- Expression of Fibroblast Growth Factor-2 and Fibroblast Growth Factor Receptor-1 in Thyroid Diseases : Difference between Neoplasms and Hyperplastic Lesions
- Development of Graves' Disease after Surgical Treatment for Thyroid Nodules : Report of Four Cases
- Development of Graves' Disease from Asymptomatic Autoimmune Thyroiditis: A Case Report
- Clinicopathological characteristics of atypical cystic duct (ACD) of the breast : Assessment of ACD as a precancerous lesion
- Novel MEN1 gene mutations in familial multiple endocrine neoplasia type 1
- Can cytological findings predict intraductal spread of breast cancer? Histopathological case-control study
- Targeting solid tumors with non-pathogenic obligate anaerobic bacteria
- Exogeneous Cytosine Deaminase Gene Expression in Bifidobacterium breve I-53-8w for Tumor-Targeting Enzyme/Prodrug Therapy
- Strong Enhancement of Recombinant Cytosine Deaminase Activity in Bifidobacterium longum for Tumor-Targeting Enzyme/Prodrug Therapy